Hinge Bio, Inc. is a privately-held biotechnology company leveraging its powerful GEM-⁠DIMER™ platform to develop therapeutics that address the problems of inadequate efficacy and resistance in infectious disease and oncology.

Biotechnology

Hinge Bio

Harold E. Barry Selick

Carin Rollins

Juha Punnonen

Carin Mueller Rollins

Joshua Carle

Robert Hershberg

Miriam Siekevitz

Curtis L. Scribner

Catherine Lucas

Daniel Capon

The Development Team at Hinge Bio, Inc. spearheads the advancement of therapeutics utilizing the GEM-DIMER™ platform, focusing on combating efficacy challenges and resistance in infectious diseases and oncology. The team, led by the Chief Development Officer and VP of Development, collaborates closely with scientists to drive preclinical and clinical research initiatives, ensuring the progression from conceptualization to market-ready solutions.

Development Team

Leadership Team

Development Team

About

Team members

Other teams at Hinge Bio

Leadership Team